The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry
Open accessAbstract
Sulfoximines have been largely disregarded in medicinal chemistry for a long time. However, recently, they have risen to the apparent level of stardom on the drug discovery scene. Considering the outstanding properties of sulfoximines, this versatile functional group has advanced to implementation in several drug discovery programs. Currently, this fashionable functional group can be found in various hit-to-lead and lead optimization studies in early stages and in several compounds currently in clinical trials. Herein, we review recent developments to demonstrate the scope and limitations of this interesting and versatile functional group in medicinal chemistry and drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Johansson, S. G. O., Bieber, T., Dahl, R., Friedmann, P. S., Lanier, B. Q., Lockey, R. F., Motala, C., Ortega Martell, J. A., Platts-Mills, T. A. E., Ring, J., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.12.591 · Cited by 2,391
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
Psoriasis Pathogenesis and Treatment
Rendon, A., & Schäkel, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061475 · Cited by 2,064
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
An overview of the antimicrobial resistance mechanisms of bacteria
C Reygaert, W., & Department of Biomedical Sciences, O. U. W. B. S. O. M. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.3.482 · Cited by 1,893
Wright, N. C., Looker, A. C., Saag, K. G., Curtis, J. R., Delzell, E. S., Randall, S., & Dawson-Hughes, B. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2269 · Cited by 1,801
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Bieber, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra074081 · Cited by 1,780
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
Griffith, O. W., & Meister, A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35980-5 · Cited by 1,683
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563
Targeting the DNA Damage Response in Cancer
O’Connor, M. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.040 · Cited by 1,518
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Deeb, K. K., Trump, D. L., & Johnson, C. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2196 · Cited by 1,419
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
The growing landscape of lysine acetylation links metabolism and cell signalling
Choudhary, C., Weinert, B. T., Nishida, Y., Verdin, E., & Mann, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3841 · Cited by 1,324
Active human immunodeficiency virus protease is required for viral infectivity
Kohl, N. E., Emini, E. A., Schleif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M., & Sigal, I. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4686 · Cited by 1,307
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
Terwilliger, T., & Abdul-Hay, M. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.53 · Cited by 1,288
Cell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Triggers, targets and treatments for thrombosis
Mackman, N. (2008) · Nature · doi:10.1038/nature06797 · Cited by 1,188
Signaling through focal adhesion kinase
Schlaepfer, D. D., Hauck, C. R., & Sieg, D. J. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00052-2 · Cited by 1,175
Psoriasis: epidemiology, clinical features, and quality of life
Langley, R. G. B., Krueger, G. G., & Griffiths, C. E. M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.033217 · Cited by 1,115
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
Korkmaz, B., Horwitz, M. S., Jenne, D. E., & Gauthier, F. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002733 · Cited by 870
The negative impact of antibiotic resistance
Friedman, N. D., Temkin, E., & Carmeli, Y. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.002 · Cited by 870
Neuroactive Insecticides: Targets, Selectivity, Resistance, and Secondary Effects
Casida, J. E., & Durkin, K. A. (2013) · Annual Review of Entomology · doi:10.1146/annurev-ento-120811-153645 · Cited by 858
Mitotic catastrophe: a mechanism for avoiding genomic instability
Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3115 · Cited by 834 · cited 2×
“200 − 203 All approved PIs (e.g., indinavir, 94 , Figure 16A), except tipranavir, feature a secondary alcohol as a peptidomimetic analogue of the tetrahedral hybridized amide linkage transition state during catalytic cleavage (see Figure 16B).”
BackgroundCCL27–CCR10 interactions regulate T cell–mediated skin inflammation
Homey, B., Alenius, H., Müller, A., Soto, H., Bowman, E. P., Yuan, W., McEvoy, L., Lauerma, A. I., Assmann, T., Bünemann, E., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-157 · Cited by 807
Arican, O., Aral, M., Sasmaz, S., & Ciragil, P. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.273 · Cited by 805
Miller, M., Schneider, J., Sathyanarayana, B. K., Toth, M. V., Marshall, G. R., Clawson, L., Selk, L., Kent, S. B. H., & Wlodawer, A. (1989) · Science · doi:10.1126/science.2686029 · Cited by 684
Review of cancer from perspective of molecular
Hassanpour, S. H., & Dehghani, M. (2017) · Journal of Cancer Research and Practice · doi:10.1016/j.jcrpr.2017.07.001 · Cited by 683
Artemisinin-Based Combination Treatment of Falciparum Malaria
Nosten, F., & White, N. J. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.181 · Cited by 673
Sulfoximines: A Neglected Opportunity in Medicinal Chemistry
Lücking, U. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302209 · Cited by 672
Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., & Tokura, Y. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.111 · Cited by 671
Expanding the medicinal chemistry synthetic toolbox
Boström, J., Brown, D. G., Young, R. J., & Keserü, G. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.116 · Cited by 665
Cyclooxygenase inhibitors – current status and future prospects
Dannhardt, G., & Kiefer, W. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01197-7 · Cited by 657
Glucokinase as Glucose Sensor and Metabolic Signal Generator in Pancreatic β-Cells and Hepatocytes
Matschinsky, F. M. (1990) · Diabetes · doi:10.2337/diab.39.6.647 · Cited by 619
A comprehensive overview on osteoporosis and its risk factors
Pouresmaeili, F., Kamali Dehghan, B., Kamarehei, M., & Yong Meng, G. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s138000 · Cited by 597
The Molecular Mechanism of Action of Artemisinin—The Debate Continues
O’Neill, P. M., Barton, V. E., & Ward, S. A. (2010) · Molecules · doi:10.3390/molecules15031705 · Cited by 595
REV-ERB and ROR nuclear receptors as drug targets
Kojetin, D. J., & Burris, T. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4100 · Cited by 576
L‐asparaginase treatment in acute lymphoblastic leukemia: A focus on Erwinia asparaginase
Pieters, R., Hunger, S. P., Boos, J., Rizzari, C., Silverman, L., Baruchel, A., Goekbuget, N., Schrappe, M., & Pui, C. (2011) · Cancer · doi:10.1002/cncr.25489 · Cited by 569
Frings, M., Bolm, C., Blum, A., & Gnamm, C. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.091 · Cited by 501
New insights into the epidemiology of childhood atopic dermatitis
Flohr, C., & Mann, J. (2014) · Allergy · doi:10.1111/all.12270 · Cited by 499
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.gl · Cited by 478
Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
Wu, P., Nielsen, T. E., & Clausen, M. H. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.008 · Cited by 457
The global implications of diabetes and cancer
Shi, Y., & Hu, F. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60886-2 · Cited by 424
Hecker, S. J., Reddy, K. R., Totrov, M., Hirst, G. C., Lomovskaya, O., Griffith, D. C., King, P., Tsivkovski, R., Sun, D., Sabet, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00127 · Cited by 422
Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets
Hussain, J., & Rea, C. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci900450m · Cited by 420
Bromodomains: a new target class for drug development
Cochran, A. G., Conery, A. R., & Sims, R. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0030-7 · Cited by 412
Cyclooxygenase-2 (COX-2)–Independent Anticarcinogenic Effects of Selective COX-2 Inhibitors
Grösch, S., Maier, T. J., Schiffmann, S., & Geisslinger, G. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj206 · Cited by 400
Inhibitors of cyclin-dependent kinases as cancer therapeutics.
Whittaker, S. R., Mallinger, A., Workman, P., & Clarke, P. A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.008 · Cited by 384
Glucokinase and molecular aspects of liver glycogen metabolism
Agius, L. (2008) · Biochemical Journal · doi:10.1042/bj20080595 · Cited by 384
Discovery and Characterization of Sulfoxaflor, a Novel Insecticide Targeting Sap-Feeding Pests
Zhu, Y., Loso, M. R., Watson, G. B., Sparks, T. C., Rogers, R. B., Huang, J. X., Gerwick, B. C., Babcock, J. M., Kelley, D., Hegde, V. B., et al. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf102765x · Cited by 382
Nonleadlikeness and leadlikeness in biochemical screening
Rishton, G. M. (2003) · Drug Discovery Today · doi:10.1016/s1359644602025722 · Cited by 381
Classification of scaffold-hopping approaches
Sun, H., Tawa, G., & Wallqvist, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.024 · Cited by 375
AMP-Activated Protein Kinase: A Target for Drugs both Ancient and Modern
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.019 · Cited by 372
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
Mehellou, Y., & De Clercq, E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900492g · Cited by 368
Sparks, T. C., Watson, G. B., Loso, M. R., Geng, C., Babcock, J. M., & Thomas, J. D. (2013) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2013.05.014 · Cited by 365
Lücking, U. (2019) · Organic Chemistry Frontiers · doi:10.1039/c8qo01233d · Cited by 364
BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease
Ghosh, A. K., & Osswald, H. L. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60460h · Cited by 358
Mutabingwa, T. K. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.06.009 · Cited by 352
Refining the definition of hypereosinophilic syndrome
Simon, H.-U., Rothenberg, M. E., Bochner, B. S., Weller, P. F., Wardlaw, A. J., Wechsler, M. E., Rosenwasser, L. J., Roufosse, F., Gleich, G. J., & Klion, A. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.03.042 · Cited by 338
Interleukin 17A: Toward a new understanding of psoriasis pathogenesis
Lynde, C. W., Poulin, Y., Vender, R., Bourcier, M., & Khalil, S. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.12.036 · Cited by 335
Foote, K. M., Nissink, J. W. M., McGuire, T., Turner, P., Guichard, S., Yates, J. W. T., Lau, A., Blades, K., Heathcote, D., Odedra, R., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01187 · Cited by 332
SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
Jacobs, R. T., Nare, B., Wring, S. A., Orr, M. D., Chen, D., Sligar, J. M., Jenks, M. X., Noe, R. A., Bowling, T. S., Mercer, L. T., et al. (2011) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001151 · Cited by 305
Vitamin D, Calcium, and Epidermal Differentiation*
BIKLE, D. D., & PILLAI, S. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-1-3 · Cited by 299
Management of drug-resistant tuberculosis
Lange, C., Dheda, K., Chesov, D., Mandalakas, A. M., Udwadia, Z., & Horsburgh, C. R. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31882-3 · Cited by 299
Eckhardt, M., Langkopf, E., Mark, M., Tadayyon, M., Thomas, L., Nar, H., Pfrengle, W., Guth, B., Lotz, R., Sieger, P., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701280z · Cited by 284
Designing the next generation of medicines for malaria control and eradication
Burrows, J. N., Hooft van Huijsduijnen, R., Möhrle, J. J., Oeuvray, C., & Wells, T. N. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-187 · Cited by 282
Buhl, T., Sulk, M., Nowak, P., Buddenkotte, J., McDonald, I., Aubert, J., Carlavan, I., Déret, S., Reiniche, P., Rivier, M., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.141 · Cited by 278
Swain, A. L., Miller, M. M., Green, J., Rich, D. H., Schneider, J., Kent, S. B., & Wlodawer, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8805 · Cited by 275
Small, P., Keith, P. K., & Kim, H. (2018) · Allergy, Asthma & Clinical Immunology · doi:10.1186/s13223-018-0280-7 · Cited by 272
Sulfonimidamides in Medicinal and Agricultural Chemistry
Chinthakindi, P. K., Naicker, T., Thota, N., Govender, T., Kruger, H. G., & Arvidsson, P. I. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610456 · Cited by 271
Hijnen, D., de Bruin-Weller, M., Oosting, B., Lebre, C., de Jong, E., Bruijnzeel-Koomen, C., & Knol, E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.12.007 · Cited by 269
Beckerandre, M., Andre, E., & Delamarter, J. F. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1976 · Cited by 250
Inhibition of Cytochromes P450 by Antifungal Imidazole Derivatives
Zhang, W., Ramamoorthy, Y., Kilicarslan, T., Nolte, H., Tyndale, R. F., & Sellers, E. M. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.3.314 · Cited by 249
Patel, V, Senderowicz, A. M., Pinto, D., Igishi, T., Raffeld, M., Quintanilla-Martinez, L., Ensley, J. F., Sausville, E. A., & Gutkind, J. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3661 · Cited by 246
Meanwell, N. A. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00043 · Cited by 239
Discovery and development of new antibacterial drugs: learning from experience?
Jackson, N., Czaplewski, L., & Piddock, L. J. V. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky019 · Cited by 238
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.012 · Cited by 237
Mapping Plasmodium falciparum Mortality in Africa between 1990 and 2015
Gething, P. W., Casey, D. C., Weiss, D. J., Bisanzio, D., Bhatt, S., Cameron, E., Battle, K. E., Dalrymple, U., Rozier, J., Rao, P. C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606701 · Cited by 233
Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3
CHRISTAKOS, S., RAVAL-PANDYA, M., WERNYJ, R. P., & YANG, W. (1996) · Biochemical Journal · doi:10.1042/bj3160361 · Cited by 231
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs
Sánchez-Martínez, C., Gelbert, L. M., Lallena, M. J., & de Dios, A. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.05.100 · Cited by 230
Where Have all the Antibiotics Gone?
Davies, J. (2006) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2006/707296 · Cited by 228
Biological characterization of sulfoxaflor, a novel insecticide
Babcock, J. M., Gerwick, C. B., Huang, J. X., Loso, M. R., Nakamura, G., Nolting, S. P., Rogers, R. B., Sparks, T. C., Thomas, J., Watson, G. B., et al. (2011) · Pest Management Science · doi:10.1002/ps.2069 · Cited by 228
Sulfoxaflor exposure reduces bumblebee reproductive success
Siviter, H., Brown, M. J. F., & Leadbeater, E. (2018) · Nature · doi:10.1038/s41586-018-0430-6 · Cited by 226
IL-17/Th17 Pathway Is Activated in Acne Lesions
Kelhälä, H.-L., Palatsi, R., Fyhrquist, N., Lehtimäki, S., Väyrynen, J. P., Kallioinen, M., Kubin, M. E., Greco, D., Tasanen, K., Alenius, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105238 · Cited by 216
The Role of Neutrophil Elastase Inhibitors in Lung Diseases
Polverino, E., Rosales-Mayor, E., Dale, G. E., Dembowsky, K., & Torres, A. (2017) · Chest · doi:10.1016/j.chest.2017.03.056 · Cited by 215
Foote, K. M., Blades, K., Cronin, A., Fillery, S., Guichard, S. S., Hassall, L., Hickson, I., Jacq, X., Jewsbury, P. J., McGuire, T. M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301859s · Cited by 214
The Balancing Act of Neutrophils
Bardoel, B. W., Kenny, E. F., Sollberger, G., & Zychlinsky, A. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.04.011 · Cited by 213
Sirvent, J. A., & Lücking, U. (2017) · ChemMedChem · doi:10.1002/cmdc.201700044 · Cited by 213
Rizzoli, R., Reginster, J.-Y., Boonen, S., Bréart, G., Diez-Perez, A., Felsenberg, D., Kaufman, J.-M., Kanis, J. A., & Cooper, C. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9499-8 · Cited by 206
Cyclooxygenase 2 inhibitors: discovery, selectivity and the future
Marnett, L. J., & Kalgutkar, A. S. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01385-1 · Cited by 205
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases
Fragoulis, G. E., Siebert, S., & McInnes, I. B. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-051914-021944 · Cited by 201
Overview of CDK9 as a target in cancer research
Morales, F., & Giordano, A. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1138186 · Cited by 196
Voynow, J. A., Fischer, B. M., & Zheng, S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.03.003 · Cited by 194
Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism
Eriksson, B. I., Quinlan, D. J., & Eikelboom, J. W. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-062209-095159 · Cited by 194
Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?
McIntosh, C. H. S., Demuth, H.-U., Pospisilik, J. A., & Pederson, R. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.001 · Cited by 192
Lücking, U., Scholz, A., Lienau, P., Siemeister, G., Kosemund, D., Bohlmann, R., Briem, H., Terebesi, I., Meyer, K., Prelle, K., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700447 · Cited by 188
Novel nicotinic action of the sulfoximine insecticide sulfoxaflor
Watson, G. B., Loso, M. R., Babcock, J. M., Hasler, J. M., Letherer, T. J., Young, C. D., Zhu, Y., Casida, J. E., & Sparks, T. C. (2011) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2011.01.009 · Cited by 187
Structural Basis for the Activity and Substrate Specificity of Erwinia chrysanthemi l -Asparaginase,
Aghaiypour, K., Wlodawer, A., & Lubkowski, J. T. (2001) · Biochemistry · doi:10.1021/bi0029595 · Cited by 187
Lücking, U., Jautelat, R., Krüger, M., Brumby, T., Lienau, P., Schäfer, M., Briem, H., Schulze, J., Hillisch, A., Reichel, A., et al. (2013) · ChemMedChem · doi:10.1002/cmdc.201300096 · Cited by 182
l-S,R-buthionine sulfoximine: historical development and clinical issues
Bailey, H. H. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00164-6 · Cited by 178
Iwata, K., Doi, A., Ohji, G., Oka, H., Oba, Y., Takimoto, K., Igarashi, W., Gremillion, D. H., & Shimada, T. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.4010 · Cited by 177
Functions, Regulation, and Therapeutic Implications of the ATR Checkpoint Pathway
Yazinski, S. A., & Zou, L. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-121415-121658 · Cited by 175
Glucagon-Like Peptide I Reduces Postprandial Glycemic Excursions in IDDM
Dupré, J., Behme, M., Hramiak, I., McFarlane, P. G., Williamson, M., Zabel, P., & Mcdonald, T. (1995) · Diabetes · doi:10.2337/diab.44.6.626 · Cited by 169
Manning, J. M., Moore, S., Rowe, W. B., & Meister, A. (1969) · Biochemistry · doi:10.1021/bi00834a066 · Cited by 166
Karasik, A., Aschner, P. J., Katzeff, H. L., Davies, M. J., & Stein, P. P. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x261069 · Cited by 163
Siemeister, G., Lücking, U., Wengner, A. M., Lienau, P., Steinke, W., Schatz, C. A., Mumberg, D., & Ziegelbauer, K. B. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0286 · Cited by 161
Buckbinder, L., Crawford, D. T., Qi, H., Ke, H. Z., Olson, L. M., Long, K. R., Bonnette, P. C., Baumann, A. P., Hambor, J. E., Grasser, W. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701421104 · Cited by 160
Emerging therapeutic opportunities for skeletal restoration
Kawai, M., Mödder, U. I., Khosla, S., & Rosen, C. J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3299 · Cited by 159
Bioisosteres in Medicinal Chemistry
Brown, N. (2012) · Wiley eBooks · doi:10.1002/9783527654307 · Cited by 158
Raj, R., Singh, P., Singh, P., Gut, J., Rosenthal, P. J., & Kumar, V. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.032 · Cited by 149
Asselin, B. L. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4811-9_69 · Cited by 142
Human neutrophil elastase functions as a type III collagen “Collagenase”
Gadek, J. E., Fells, G. A., Wright, D. G., & Crystal, R. G. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(80)80110-0 · Cited by 142
Conversion and degradation pathways of sulfoximines
Wiezorek, S., Lamers, P., & Bolm, C. (2019) · Chemical Society Reviews · doi:10.1039/c9cs00483a · Cited by 141
Inhibition of γ-Glutamylcysteine Synthetase by l-Methionine-S-sulfoximine
Richman, P. G., Orłowski, M., & Meister, A. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43407-8 · Cited by 139
DIVO, A. A., Geary, T. G., & Jensen, J. B. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.1.21 · Cited by 139
Neutrophil elastase in bronchiectasis
Gramegna, A., Amati, F., Terranova, L., Sotgiu, G., Tarsia, P., Miglietta, D., Calderazzo, M. A., Aliberti, S., & Blasi, F. (2017) · Respiratory Research · doi:10.1186/s12931-017-0691-x · Cited by 131
Sulfonimidamides: Synthesis and Applications in Preparative Organic Chemistry
Nandi, G. C., & Arvidsson, P. I. (2018) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201800273 · Cited by 131
AMP-activated protein kinase: A target for old drugs against diabetes and cancer
Russo, G. L., Russo, M., & Ungaro, P. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.023 · Cited by 122
Kawasaki, Y., & Aikawa, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s65066 · Cited by 122
Yéni, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.021 · Cited by 118
Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents
Marnett, L. J., & Kalgutkar, A. S. S. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80124-5 · Cited by 116
Buckheit, R. W., Fliakas-Boltz, V., Decker, W. D., Roberson, J. L., Pyle, C., White, E. L., Bowdon, B. J., McMahon, J. B., Boyd, M. R., Bader, J. P., et al. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90092-2 · Cited by 113
Pfefferkorn, J. A., Guzmán-Pérez, A., Litchfield, J., Aiello, R. J., Treadway, J. L., Pettersen, J. C., Minich, M. L., Filipski, K. J., Jones, C. S., Tu, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2014887 · Cited by 113
Glucokinase, glucose homeostasis, and diabetes mellitus
Matschinsky, F. M. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0005-4 · Cited by 113
Stable Association of PYK2 and p130Cas in Osteoclasts and Their Co-localization in the Sealing Zone
Lakkakorpi, P. T., Nakamura, I., Nagy, R. M., Parsons, J. T., Rodan, G. A., & Duong, L. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4900 · Cited by 112
Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target
Kryštof, V., Baumli, S., & Fürst, R. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800672750 · Cited by 112
Novel Pharmacological Approaches to the Treatment of Type 2 Diabetes
Verspohl, E. J. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003319 · Cited by 112
Antimalarial agents: mechanisms of action
Schlesinger, P. H., Krogstad, D. J., & Herwaldt, B. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.6.793 · Cited by 111
Perspective: Nonreproductive Sites of Action of Reproductive Hormones
Manolagas, S. C., & Kousteni, S. (2001) · Endocrinology · doi:10.1210/endo.142.6.8221 · Cited by 108
Glucokinase Activators for Diabetes Therapy
Matschinsky, F. M., Zelent, B., Doliba, N. M., Li, C., Vanderkooi, J. M., Naji, A., Sarabu, R., & Grimsby, J. S. (2011) · Diabetes Care · doi:10.2337/dc11-s236 · Cited by 107
Neutrophil elastase inhibitors as treatment for COPD
Ohbayashi, H. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.7.965 · Cited by 107
Targeting COPD: advances on low‐molecular‐weight inhibitors of human neutrophil elastase
Lucas, S. D., Costa, E., Guedes, R. C., & Moreira, R. (2011) · Medicinal Research Reviews · doi:10.1002/med.20247 · Cited by 107
N‐Cyano Sulfoximines: COX Inhibition, Anticancer Activity, Cellular Toxicity, and Mutagenicity
Park, S. J., Baars, H., Mersmann, S., Buschmann, H., Baron, J. M., Amann, P. M., Czaja, K., Hollert, H., Bluhm, K., Redelstein, R., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200403 · Cited by 103
Sehgelmeble, F. W., Janson, J., Ray, C., Rosqvist, S., Gustavsson, S., Nilsson, L. I., Minidis, A. B. E., Holenz, J., Rotticci, D., Lundkvist, J., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200014 · Cited by 103
Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin
Smith, S. H., Peredo, C. E., Takeda, Y., Bui, T. T., Neil, J. E., Rickard, D. J., Millerman, E., Therrien, J., Nicodème, E., Brusq, J.-M. G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147979 · Cited by 99
Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors
Lloyd, D. J., Jean, D. J. S., Kurzeja, R. J. M., Wahl, R. C., Michelsen, K., Cupples, R. L., Chen, M., Wu, J. W. Y., Sivits, G. N., Helmering, J., et al. (2013) · Nature · doi:10.1038/nature12724 · Cited by 95
Visser, B. J., Wieten, R. W., Kroon, D., Nagel, I. M., Bélard, S., van Vugt, M., & Grobusch, M. P. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-463 · Cited by 95
Glucagon-like peptide 1 improved glycemic control in type 1 diabetes
Behme, M. T., Dupré, J., & McDonald, T. J. (2003) · BMC Endocrine Disorders · doi:10.1186/1472-6823-3-3 · Cited by 93
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease
Panza, F., Lozupone, M., Solfrizzi, V., Sardone, R., Piccininni, C., Dibello, V., Stallone, R., Giannelli, G., Bellomo, A., Greco, A., et al. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1531706 · Cited by 92
Derivation and differentiation of glomerular endothelial cells
Abrahamson, D. R., & Robert, B. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg1056 · Cited by 91
Kutchukian, P. S., Vasilyeva, N. Y., Xu, J. C., Lindvall, M., Dillon, M. P., Glick, M., Coley, J. D., & Brooijmans, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048476 · Cited by 90
Walker, D. P., Zawistoski, M. P., McGlynn, M. A., Li, J., Kung, D. W., Bonnette, P. C., Baumann, A. P., Buckbinder, L., Houser, J. A., Boer, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.093 · Cited by 89
Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
Deacon, C. F. (2018) · Peptides · doi:10.1016/j.peptides.2017.10.011 · Cited by 89
Bioactive sulfoximines: Syntheses and properties of Vioxx® analogs
Park, S. J., Buschmann, H., & Bolm, C. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.029 · Cited by 84
Jackson, S. P., & Helleday, T. (2016) · Science · doi:10.1126/science.aab0958 · Cited by 81
Stockley, R. A. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.001 · Cited by 77
Mahalingam, B., Wang, Y., Boross, P. I., Tőzsér, J., Louis, J. M., Harrison, R. W., & Weber, I. T. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04060.x · Cited by 76
Cho, S., Schroeder, S., & Ott, M. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11346 · Cited by 74
Vitamin D deficiency and aging: implications for general health and osteoporosis
Eriksen, E. F., & Glerup, H. (2002) · Biogerontology · doi:10.1023/a:1015263514765 · Cited by 71
Siviter, H., Scott, A., Pasquier, G., Pull, C. D., Brown, M. J. F., & Leadbeater, E. (2019) · PeerJ · doi:10.7717/peerj.7208 · Cited by 66
von Nussbaum, F., Li, V. M. ‐., Allerheiligen, S., Anlauf, S., Bärfacker, L., Bechem, M., Delbeck, M., Fitzgerald, M. F., Gerisch, M., Gielen‐Haertwig, H., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500131 · Cited by 65
Siemeister, G., Luecking, U., Wagner, C., Detjen, K. M., Coy, C. M., & Bosslet, K. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.06.003 · Cited by 62
Hypersensitivity reactions to antineoplastic agents: an overview
Syrigou, E. I., Makrilia, N., Koti, I., Saif, M. W., & Syrigos, K. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32831961b3 · Cited by 60
Cyclooxygenase inhibitors: Scope of their use and development in cancer chemotherapy
Khan, M. N. A., & Lee, Y. S. (2009) · Medicinal Research Reviews · doi:10.1002/med.20182 · Cited by 59
The isolation of a toxic substance from agenized wheat flour
Campbell, P. N., Work, T. S., & Mellanby, E. (1951) · Biochemical Journal · doi:10.1042/bj0480106 · Cited by 59
Pereira, G. R., Brandão, G. C., Arantes, L. M., de Oliveira, H. A., de Paula, R. C., do Nascimento, M. F. A., dos Santos, F. M., da Rocha, R. K., Lopes, J. C. D., & de Oliveira, A. B. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.022 · Cited by 58
Nishimura, N., Norman, M. H., Liu, L., Yang, K., Ashton, K. S., Bartberger, M. D., Chmait, S., Chen, J., Cupples, R. L., Fotsch, C. H., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000497 · Cited by 58
Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases
Klein, K. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000744 · Cited by 58
Gutierrez, J. A., Pan, Y., Koroniak, Ł., Hiratake, J., Kilberg, M. S., & Richards, N. G. J. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.10.010 · Cited by 56
Reinhardt, T. A., & Horst, R. L. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90240-3 · Cited by 54
Malaria in developing countries
del Prado, G. R. L., García, C., Cea, L. M., Espinilla, V. F., Muñoz-Moreno, M. F., Márquez, A. D., Polo, M. J. P., & García, I. (2014) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.4610 · Cited by 54
Banerjee, D., Zhao, L., Wu, L., Palanichamy, A., Ergün, A., Peng, L., Quigley, C., Hamann, S., Dunstan, R. W., Cullen, P. F., et al. (2015) · Immunology · doi:10.1111/imm.12570 · Cited by 53
Vitamin D analogues targeting CYP24 in chronic kidney disease
Posner, G. H., Helvig, C. F., Cuerrier, D., Collop, D., Kharebov, A. Z., Ryder, K., Epps, T., & Petkovich, M. P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.065 · Cited by 50
Chiral Analogues of PFI-1 as BET Inhibitors and Their Functional Role in Myeloid Malignancies
Altenburg, B., Frings, M., Schöbel, J., Goßen, J., Pannen, K., Vanderliek, K., Rossetti, G., Koschmieder, S., Chatain, N., & Bolm, C. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00625 · Cited by 48
Ikeuchi, H., Ahn, Y., Otokawa, T., Watanabe, B., Hegazy, L., Hiratake, J., & Richards, N. G. J. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.07.047 · Cited by 47
Anderka, O., Boyken, J., Aschenbach, U., Batzer, A., Boscheinen, O., & Schmoll, D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805434200 · Cited by 46
Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality
Ding, L., & Vince, R. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.095 · Cited by 44
Zhu, W., Radadiya, A., Bisson, C., Wenzel, S., Nordin, B. E., Martínez-Márquez, F., Imasaki, T., Sedelnikova, S. E., Coricello, A., Baumann, P., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0587-z · Cited by 42
Prediction of the P. falciparum Target Space Relevant to Malaria Drug Discovery
Spitzmüller, A., & Mestres, J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003257 · Cited by 41
Ding, L., Sham, Y. Y., & Vince, R. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.020 · Cited by 41
Steinkamp, A., Schmitt, L., Chen, X., Fietkau, K., Heise, R., Baron, J. M., & Bolm, C. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000453042 · Cited by 38
Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists
Ouvry, G., Bouix‐Peter, C., Ciesielski, F., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.10.023 · Cited by 37
Cho, B. C., Dy, G. K., Govindan, R., Kim, D., Pennell, N. A., Zalcman, G., Besse, B., Kim, J.-H., Koca, G., Rajagopalan, P., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.04.022 · Cited by 35
Scott, E. N., Thomas, A., Molife, L. R., Ahmed, S. I., Blagden, S. P., Fong, P. C. C., Kowal, K., McCoy, C., Wiesinger, H., Steward, W. P., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-0968-y · Cited by 34
Hernández‐Breijo, B., Monserrat, J., Ramirez-Rubio, S., Cuevas, E. P., Vara‐Ciruelos, D., Díaz‐Laviada, I., Fernández-Moreno, M. D., Román, I. D., Gisbert, J. P., & Guijarro, L. G. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i34.3899 · Cited by 34
Viral gene products and replication of the human immunodeficiency type 1 virus
Morrow, C. D., Park, J., & Wakefield, J. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.5.c1135 · Cited by 34
Ashton, K. S., Andrews, K. L., Bryan, M. C., Chen, J., Chen, K., Chen, M., Chmait, S., Croghan, M. D., Cupples, R. L., Fotsch, C. H., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4016735 · Cited by 33
Review of phase III trial data on IL ‐23 inhibitors tildrakizumab and guselkumab for psoriasis
Amin, M., Darji, K., No, D. J., & Wu, J. J. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14451 · Cited by 31
Jean, D. J. S., Ashton, K. S., Bartberger, M. D., Chen, J., Chmait, S., Cupples, R. L., Galbreath, E. J., Helmering, J., Hong, F., Jordan, S. R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4016747 · Cited by 29
Hamid, O., Ilaria, R. L., Garbe, C., Wolter, P., Maio, M., Hutson, T. E., Arance, A. M., Lorigan, P. C., Lee, J., Hauschild, A., et al. (2014) · Cancer · doi:10.1002/cncr.28635 · Cited by 28
Oral anticoagulants in the management of venous thromboembolism
Makaryus, J. N., Halperin, J. L., & Lau, J. F. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.73 · Cited by 28
Cited by
Murray, P. R. D., Cox, J. H., Chiappini, N. D., Roos, C. B., McLoughlin, E. A., Hejna, B. G., Nguyen, S. T., Ripberger, H. H., Ganley, J. M., Tsui, E., et al. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00374 · Cited by 588
Metadata
- Authors
- Mäder, P., & Kattner, L.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-09-01
- Volume
- 63
- Issue
- 23
- Pages
- 14243-14275
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3082339478
- Cited by
- 438
- References
- 212
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.